Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses

References

• Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. Embo J 15:1914–1923.
   PubMed Web of Science ®Google Scholar
• Brinckerhoff CE, Matrisian LM. 2002. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3:207–214.
   PubMed Web of Science ®Google Scholar
• Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395.
   PubMed Web of Science ®Google Scholar
• Clark RA, Mason RJ, Folkvord JM, Mcdonald JA. 1986. Fibronectin mediates adherence of rat alveolar type II epithelial cells via the fibroblastic cell-attachment domain. J Clin Invest 77:1831–1840.
   PubMed Web of Science ®Google Scholar
• Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, Du Bois RM, Jeffery PK, 1997. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 150:981–991.
   PubMed Web of Science ®Google Scholar
• Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, 2004. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 170:242–251.
   PubMed Web of Science ®Google Scholar
• Crouch E. 1990. Pathobiology of pulmonary fibrosis. Am J Physiol 259:L159–L184.
   PubMed Web of Science ®Google Scholar
• Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, 2004. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 114:1308–1316.
   PubMed Web of Science ®Google Scholar
• Demyanets S, Kaun C, Rychli K, Pfaffenberger S, Kastl SP, Hohensinner PJ, 2011. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-gamma. Basic Res Cardiol 106:217–231.
   PubMed Web of Science ®Google Scholar
• Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M. 1999. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat Rec 254:61–73.
   PubMedGoogle Scholar
• Goldberg PL, Macnaughton DE, Clements RT, Minnear FL, Vincent PA. 2002. p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability. Am J Physiol Lung Cell Mol Physiol 282:L146–L154.
   PubMed Web of Science ®Google Scholar
• Han J, Lee JD, Bibbs L, Ulevitch RJ. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808–811.
   PubMed Web of Science ®Google Scholar
• Helmlinger G, Endo M, Ferrara N, Hlatky L, Jain RK. 2000. Formation of endothelial cell networks. Nature 405:139–141.
   PubMed Web of Science ®Google Scholar
• Hiratsuka S, Duda DG, Huang Y, Goel S, Sugiyama T, Nagasawa T, 2011. C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells. Proc Natl Acad Sci USA 108:302–307.
   PubMedGoogle Scholar
• Huh JE, Nam DW, Baek YH, Kang JW, Park DS, Choi DY, 2011. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways. Int Immunopharmacol 11:46–54.
   PubMed Web of Science ®Google Scholar
• Inghilleri S, Morbini P, Oggionni T, Barni S, Fenoglio C. 2006. In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis. Histochem Cell Biol 125:661–669.
   PubMed Web of Science ®Google Scholar
• Iordanov M, Bender K, Ade T, Schmid W, Sachsenmaier C, Engel K, 1997. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. Embo J 16:1009–1022.
   PubMedGoogle Scholar
• Kang HR, Lee CG, Homer RJ, Elias JA. 2007. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med 204:1083–1093.
   PubMed Web of Science ®Google Scholar
• Keane MP, Arenberg DA, Lynch JP 3rd, Whyte RI, Iannettoni MD, Burdick MD, 1997. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 159:1437–1443.
   PubMed Web of Science ®Google Scholar
• Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, Xue YY, 1999a. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 163:5686–5692.
   PubMed Web of Science ®Google Scholar
• Keane MP, Belperio JA, Burdick MD, Lynch JP, Fishbein MC, Strieter RM. 2001. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 164:2239–2242.
   PubMed Web of Science ®Google Scholar
• Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, 1999b. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol 162:5511–5518.
   PubMed Web of Science ®Google Scholar
• Khalil N, Parekh TV, O'Connor R, Antman N, Kepron W, Yehaulaeshet T, 2001. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis. Thorax 56:907–915.
   PubMed Web of Science ®Google Scholar
• Kolosova I, Nethery D, Kern JA. 2011. Role of Smad2/3 and p38 MAP kinase in TGF-beta1-induced epithelial-mesenchymal transition of pulmonary epithelial cells. J Cell Physiol 226:1248–1254.
   PubMed Web of Science ®Google Scholar
• Lam CW, James JT, Mccluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126–134.
   PubMed Web of Science ®Google Scholar
• Lu Y, Azad N, Wang L, Iyer AK, Castranova V, Jiang BH, 2010. Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am J Respir Cell Mol Biol 42:432–441.
   PubMed Web of Science ®Google Scholar
• Mcanulty RJ, Laurent GJ. 1995. Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp Nephrol 3:96–107.
   PubMedGoogle Scholar
• Meyer KC, Cardoni A, Xiang ZZ. 2000. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 135:332–338.
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Toyoshima F, Gotoh Y, Iwamatsu A, Irie K, Mori E, 1996. Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-alpha, and H2O2. J Biol Chem 271:26981–26988.
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839.
   PubMed Web of Science ®Google Scholar
• Pandey P, Raingeaud J, Kaneki M, Weichselbaum R, Davis RJ, Kufe D, 1996. Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms. J Biol Chem 271:23775–23779.
   PubMedGoogle Scholar
• Papakonstantinou E, Aletras AJ, Roth M, Tamm M, Karakiulakis G. 2003. Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts. Cytokine 24:25–35.
   PubMed Web of Science ®Google Scholar
• Pardo A, Selman M. 2005. MMP-1: the elder of the family. Int J Biochem Cell Biol 37:283–288.
   PubMed Web of Science ®Google Scholar
• Peao MN, Aguas AP, De Sa CM, Grande NR. 1994. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 238:57–67.
   PubMedGoogle Scholar
• Pelton RW, Nomura S, Moses HL, Hogan BL. 1989. Expression of transforming growth factor beta 2 RNA during murine embryogenesis. Development 106:759–767.
   PubMed Web of Science ®Google Scholar
• Quinlan T, Spivack S, Mossman BT. 1994. Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 102(Suppl 2):79–87.
   PubMedGoogle Scholar
• Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420–7426.
   PubMed Web of Science ®Google Scholar
• Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, 2003. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 167:438–443.
   PubMed Web of Science ®Google Scholar
• Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, 1986. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–4171.
   PubMed Web of Science ®Google Scholar
• Roos TU, Heiss EH, Schwaiberger AV, Schachner D, Sroka IM, Oberan T, 2011. Caffeic acid phenethyl ester inhibits PDGF-Induced proliferation of vascular smooth muscle cells via activation of p38 MAPK, HIF-1alpha, and Heme Oxygenase-1. J Nat Prod 74:352–356.
   PubMed Web of Science ®Google Scholar
• Selman M, King TE, Pardo A. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134:136–151.
   PubMed Web of Science ®Google Scholar
• Selman M, Montano M, Ramos C, Chapela R. 1986. Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax 41:355–359.
   PubMed Web of Science ®Google Scholar
• Shields KM, Panzhinskiy E, Burns N, Zawada WM, Das M. 2011. Mitogen-activated protein kinase phosphatase-1 is a key regulator of hypoxia-induced vascular endothelial growth factor expression and vessel density in lung. Am J Pathol 178:98–109.
   PubMedGoogle Scholar
• Shvedova AA, Kagan VE. 2010. The role of nanotoxicology in realizing the 'helping without harm' paradigm of nanomedicine: lessons from studies of pulmonary effects of single-walled carbon nanotubes. J Intern Med 267:106–118.
   PubMed Web of Science ®Google Scholar
• Shvedova AA, Kisin E, Murray AR, Johnson VJ, Gorelik O, Arepalli S, 2008. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol 295:L552–L565.
   PubMed Web of Science ®Google Scholar
• Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, 2005. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289:L698–L708.
   PubMed Web of Science ®Google Scholar
• Sorensen V, Zhen Y, Zakrzewska M, Haugsten EM, Walchli S, Nilsen T, 2008. Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus. Mol Cell Biol 28:4129–4141.
   PubMedGoogle Scholar
• Steurer M, Zoller H, Augustin F, Fong D, Heiss S, Strasser-Weippl K, 2007. Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor. Hum Pathol 38:1057–1064.
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Toews GB, White ES, Lynch JP 3rd, Martinez FJ. 2004. Mechanisms of pulmonary fibrosis. Annu Rev Med 55:395–417.
   PubMed Web of Science ®Google Scholar
• Turner-Warwick M. 1963. Precapillary Systemic-Pulmonary Anastomoses. Thorax 18:225–237.
   PubMedGoogle Scholar
• Wang L, Castranova V, Mishra A, Chen B, Mercer RR, Schwegler-Berry D, 2010a. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol 7:31.
   PubMed Web of Science ®Google Scholar
• Wang L, Mercer RR, Rojanasakul Y, Qiu A, Lu Y, Scabilloni JF, 2010b. Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts. J Toxicol Environ Health A 73:410–422.
   PubMed Web of Science ®Google Scholar
• Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77:117–125.
   PubMed Web of Science ®Google Scholar
• Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, 2001. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Cancer Res 61:1727–1732.
   PubMed Web of Science ®Google Scholar
• Xu YD, Hua J, Mui A, O'Connor R, Grotendorst G, Khalil N. 2003. Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 285:L527–L539.
   PubMed Web of Science ®Google Scholar
• Yang EY, Moses HL. 1990. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731–741.
   PubMed Web of Science ®Google Scholar
• Zhang P, Xu D, Wang S, FU H, Wang K, Zou Y, 2011. Inhibition of aldehyde dehydrogenase 2 activity enhances antimycin-induced rat cardiomyocytes apoptosis through activation of MAPK signaling pathway. Biomed Pharmacother 65(8):590–593.
   PubMedGoogle Scholar